Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Scarring of the lung parenchyma caused by pulmonary tuberculosis.
Biomarker and diagnostic research for tuberculous fibrosis of lung has been reported in the published literature.
No clinical trials have been registered for tuberculous fibrosis of lung.
201 publications have been identified in PubMed for tuberculous fibrosis of lung. Kisho has analyzed 127 by research type. Research spans Review / Meta-Analysis (44%), Epidemiology / Natural History (24%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 56 | 44% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:48 PM UTC
Disease patterns and progression |
30 |
24% |
Laboratory research | 19 | 15% |
Clinical study results | 7 | 6% |
New treatment approaches | 6 | 5% |
Testing and diagnosis research | 5 | 4% |
Other research | 2 | 2% |
Patient case studies | 2 | 2% |
Al-Hindawi Y (2026). [PMID: 41607640](https://pubmed.ncbi.nlm.nih.gov/41607640/). *Breathe (Sheff)*. [Review / Meta-Analysis]
Sundaram K (2026). [PMID: 41637771](https://pubmed.ncbi.nlm.nih.gov/41637771/). *J Mycol Med*. [Review / Meta-Analysis]
Nouma Y (2026). [PMID: 42096982](https://pubmed.ncbi.nlm.nih.gov/42096982/). *J Forensic Leg Med*. [Review / Meta-Analysis]
Khalaili L (2026). [PMID: 40610053](https://pubmed.ncbi.nlm.nih.gov/40610053/). *Eur Respir J*. [Epidemiology / Natural History]
Murthy MK (2026). [PMID: 42179456](https://pubmed.ncbi.nlm.nih.gov/42179456/). *New Microbes New Infect*. [Review / Meta-Analysis]
Schrader C (2026). [PMID: 41812027](https://pubmed.ncbi.nlm.nih.gov/41812027/). *Hepatology*. [Clinical Trial Publication]
Joy N (2026). [PMID: 41571441](https://pubmed.ncbi.nlm.nih.gov/41571441/). *Life Sci Alliance*. [Basic Science / Preclinical]
Huang P (2026). [PMID: 41099951](https://pubmed.ncbi.nlm.nih.gov/41099951/). *Mol Cell Biochem*. [Review / Meta-Analysis]
Yamamoto S (2026). [PMID: 41534709](https://pubmed.ncbi.nlm.nih.gov/41534709/). *Chest*. [Review / Meta-Analysis]
Mbano IM (2026). [PMID: 41489684](https://pubmed.ncbi.nlm.nih.gov/41489684/). *J Exp Med*. [Basic Science / Preclinical]
AI-curated news mentioning tuberculous fibrosis of lung
Updated Aug 14, 2026
A corrigendum has been issued for the study on fluvoxamine's effects on bleomycin-induced lung fibrosis, highlighting its role in regulating the cGAS-STING pathway. This research contributes to understanding potential therapeutic approaches for lung fibrosis.
A recent study highlights post varicella lung fibrosis as a significant complication following viral pneumonia. This research underscores the long-term pulmonary impacts of varicella infection, warranting further investigation into treatment options.